Pharmaceutical Data and Retrospective Pricing Analysis SaaS

Software as a Service provider (SaaS) that obtains general pharmaceutical data and retrospective pricing and synthesizes clinical pipeline data and medical/pharmacy benefit crosswalks specific to Medicaid into a single platform. This platform must be able to provide forward-looking, loss-of-exclusivity projections required for proactive Medicaid fiscal forecasting and single preferred drug list management and blends patent law with pharmacy clinical/financial forecasting.
- Provide comprehensive pharmacy and therapeutic management strategy, supporting formulary, clinical, contracting, and market-access decisions. Also provide In-depth analysis regarding drug availability, clinical data, clinical pipeline tracking, evidence-based clinical pathways, preferred products, and site of care, disease class-specific strategy reports, drug alerts, pipeline trend reports, and new-drug reviews, assessments of potential new brand product prevalence and pricing impacts prior to launch.
A. Optimize FTE resource allocation dedicated to forecasting, monitoring and validating drug pricing/coding and market insights
B. Proactively identify new cost saving, outcome improving management opportunities through enhanced visibility on the changing market landscape
C. Accurately forecast financial implications on shifts in the drug landscape
D. Inform your executives proactively on changes and opportunities in the pharmaceutical landscape.
- Pharmaceutical Data and Retrospective Pricing Analytics Service as a Software platform (Saas) shall process data from thousands of sources, combine it with proprietary research, and works to normalize, analyze, and summarize it.